BioVie Inc. Additional Paid in Capital, Common Stock
BioVie Inc. (BIVI) had Additional Paid in Capital, Common Stock of $384.53 million as of 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-13
- 2026-06-30: Additional Paid in Capital, Common Stock $384.53M.
- 2026-03-31: Additional Paid in Capital, Common Stock $384.22M.
- 2025-12-31: Additional Paid in Capital, Common Stock $382.61M.
- 2025-09-30: Additional Paid in Capital, Common Stock $382.20M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $384.53M 10-K · filed 2026-08-13 | |
| 2026-03-31 | $384.22M S-1/A · filed 2026-08-06 | |
| 2025-12-31 | $382.61M 10-Q · filed 2026-02-06 | |
| 2025-09-30 | $382.20M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $371.16M 10-K · filed 2026-08-13 | $371.15M 10-K · filed 2025-08-15 |
| 2025-03-31 | $370.47M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $369.78M 10-Q · filed 2025-02-11 | |
| 2024-09-30 | $352.77M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $349.73M S-1/A · filed 2026-08-06 | |
| 2024-03-31 | $348.21M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $327.82M 10-Q · filed 2024-02-13 | |
| 2023-09-30 | $319.48M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $316.39M 10-K · filed 2024-09-30 | |
| 2023-03-31 | $313.81M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $303.14M 10-Q · filed 2023-02-10 | |
| 2022-09-30 | $267.34M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $254.64M 10-K · filed 2023-08-16 | |
| 2022-03-31 | $252.83M 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $251.90M 10-Q · filed 2022-02-08 | |
| 2021-09-30 | $250.66M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $229.93M 10-K · filed 2022-09-27 | |
| 2021-03-31 | $104.75M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $103.43M 10-Q · filed 2021-01-29 | |
| 2020-09-30 | $101.90M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $19.54M 10-K · filed 2021-08-30 | |
| 2020-03-31 | $19.54M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $19.47M 10-Q · filed 2020-02-13 | |
| 2019-09-30 | $19.40M 10-Q · filed 2019-11-19 | |
| 2019-06-30 | $9.39M 10-K/A · filed 2020-08-07 | $9.34M 10-K · filed 2019-09-27 |
| 2019-05-10 | $9.36M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $9.27M 10-Q · filed 2019-02-12 | |
| 2018-09-30 | $9.25M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $4.87M 10-K · filed 2019-09-27 | |
| 2018-03-31 | $4.74M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $4.28M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $4.07M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $3.48M 10-K · filed 2018-10-05 | |
| 2017-03-31 | $3.37M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $3.03M 10-Q · filed 2017-02-07 | |
| 2016-09-30 | $2.93M 10-Q/A · filed 2017-01-19 | |
| 2016-06-30 | $2.91M 10-K · filed 2017-08-24 | |
| 2016-03-31 | $514.49K 10-Q · filed 2016-05-23 | |
| 2015-12-31 | $514.49K 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $514.49K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $514.49K 10-K · filed 2016-09-28 | |
| 2015-03-31 | $514.49K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $514.49K 10-Q · filed 2015-02-05 | |
| 2014-09-30 | $514.49K 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $514.49K 10-K · filed 2015-10-01 | |
| 2014-03-31 | $514.49K 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $499.50K 10-Q · filed 2014-01-29 | |
| 2013-09-30 | $499.50K 10-Q · filed 2013-11-13 | |
| 2013-06-30 | $499.50K 10-K · filed 2014-09-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |